Assyro AI

Orange Book product · Brand (NDA)

KYBELLA

DEOXYCHOLIC ACID

Brand (NDA)NDA 206333TE APRX ABBVIE

At a glance

Apr 29, 2015

Approved

Brand (NDA)

Application

AP

TE code

14

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 29, 2015

    11 yr 4 mo ago

  2. Today

  3. Patent 7622130 expires

    Listed method-of-use patent (U-1690) expiration.

    Dec 10, 2027

    in 1 yr 6 mo

  4. Patent 7754230 expires

    Listed method-of-use patent (U-1690) expiration.

    Dec 10, 2027

    in 1 yr 6 mo

  5. Patent 8461140 expires

    Listed drug product patent expiration.

    Feb 21, 2028

    in 1 yr 8 mo

  6. Patent 8546367 expires

    Listed drug product patent expiration.

    Feb 21, 2028

    in 1 yr 8 mo

  7. Patent 8883770 expires

    Listed drug product patent expiration.

    Feb 21, 2028

    in 1 yr 8 mo

  8. Patent 9522155 expires

    Listed drug product patent expiration.

    Feb 21, 2028

    in 1 yr 8 mo

  9. Patent 9636349 expires

    Listed method-of-use patent (U-1940) expiration.

    Feb 21, 2028

    in 1 yr 8 mo

  10. Patent 9949986 expires

    Listed method-of-use patent (U-1940) expiration.

    Feb 21, 2028

    in 1 yr 8 mo

  11. Patent 8242294 expires

    Listed drug substance patent expiration.

    May 16, 2028

    in 1 yr 11 mo

  12. Patent 10500214 expires

    Listed drug product patent expiration.

    Mar 02, 2030

    in 3 yr 9 mo

  13. Patent 8101593 expires

    Listed drug product patent expiration.

    Mar 02, 2030

    in 3 yr 9 mo

  14. Patent 8367649 expires

    Listed drug product patent expiration.

    Mar 02, 2030

    in 3 yr 9 mo

  15. Patent 8653058 expires

    Listed drug product patent expiration.

    Mar 02, 2030

    in 3 yr 9 mo

  16. Patent 12161653 expires

    Listed method-of-use patent (U-1940) expiration.

    Feb 17, 2032

    in 5 yr 9 mo

Pharmaceutical detail

Active ingredient

DEOXYCHOLIC ACID

Strength

20MG/2ML (10MG/ML)

Dosage form

SOLUTION

Route

SUBCUTANEOUS

TE code

AP

Application

NDA 206333

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (14)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7622130Dec 10, 2027in 1 yr 6 mo
U-1690
7754230Dec 10, 2027in 1 yr 6 mo
U-1690
8461140Feb 21, 2028in 1 yr 8 mo
Product
8546367Feb 21, 2028in 1 yr 8 mo
ProductU-1690
8883770Feb 21, 2028in 1 yr 8 mo
Product
9522155Feb 21, 2028in 1 yr 8 mo
ProductU-1940
9636349Feb 21, 2028in 1 yr 8 mo
U-1940
9949986Feb 21, 2028in 1 yr 8 mo
U-1940
8242294May 16, 2028in 1 yr 11 mo
Substance
10500214Mar 02, 2030in 3 yr 9 mo
Product
8101593Mar 02, 2030in 3 yr 9 mo
Product
8367649Mar 02, 2030in 3 yr 9 mo
Product
8653058Mar 02, 2030in 3 yr 9 mo
Product
12161653Feb 17, 2032in 5 yr 9 mo
U-1940
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.